Gilead Sciences Diversifies into Kinase Biology

By Staff Editor

Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)

Published: 2 Sep-2010

DOI: 10.3833/pdr.v2010.i7.1358     ISSN: 1756-7874

Section: Mergers & Acquisitions



Gilead Sciences, best known for its successful HIV portfolio, has made its first venture into the kinase arena by acquiring CGI Pharmaceuticals...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details